Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,016 | 563 | 97.4% |
| Education | $266.84 | 10 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,495 | 122 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $834.12 | 45 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $758.02 | 31 | $0 (2023) |
| Amgen Inc. | $743.16 | 47 | $0 (2024) |
| Allergan, Inc. | $654.76 | 46 | $0 (2020) |
| Lilly USA, LLC | $532.53 | 30 | $0 (2024) |
| GlaxoSmithKline, LLC. | $532.18 | 25 | $0 (2024) |
| Radius Health, Inc. | $514.41 | 21 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $440.82 | 25 | $0 (2024) |
| PFIZER INC. | $403.19 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $779.47 | 42 | Amgen Inc. ($134.29) |
| 2023 | $904.14 | 52 | Novo Nordisk Inc ($136.30) |
| 2022 | $1,095 | 65 | Novo Nordisk Inc ($216.00) |
| 2021 | $1,712 | 109 | Novo Nordisk Inc ($389.52) |
| 2020 | $1,699 | 103 | Novo Nordisk Inc ($302.70) |
| 2019 | $811.07 | 56 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($211.96) |
| 2018 | $2,057 | 82 | Medtronic Vascular, Inc. ($294.70) |
| 2017 | $1,226 | 64 | SANOFI-AVENTIS U.S. LLC ($354.72) |
All Payment Transactions
573 individual payment records from CMS Open Payments — Page 3 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Inflammation | ||||||
| 10/12/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Diabetes | ||||||
| 09/27/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Diabetes Care | ||||||
| 09/27/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: Diabetes | ||||||
| 09/21/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Cardio-renal | ||||||
| 09/19/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Diabetes | ||||||
| 09/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Respiratory | ||||||
| 08/24/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Diabetes | ||||||
| 08/08/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Inflammation | ||||||
| 08/03/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Diabetes Care | ||||||
| 08/03/2023 | Radius Health, Inc. | — | Food and Beverage | In-kind items and services | $13.78 | General |
| 08/01/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: RESPIRATORY | ||||||
| 07/27/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Cardio-renal | ||||||
| 07/19/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/19/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: ANTIBIOTIC | ||||||
| 07/13/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Diabetes | ||||||
| 07/13/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Gastroenterology | ||||||
| 06/30/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: Diabetes | ||||||
| 06/27/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Respiratory | ||||||
| 06/12/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Diabetes | ||||||
| 05/30/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: RESPIRATORY | ||||||
| 05/25/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Bone Health | ||||||
| 05/22/2023 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/08/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 3,845 | 13,289 | $608,852 | $284,215 |
| 2022 | 32 | 3,915 | 11,579 | $586,317 | $264,276 |
| 2021 | 35 | 4,784 | 12,291 | $671,017 | $295,778 |
| 2020 | 38 | 4,667 | 17,382 | $706,627 | $263,937 |
All Medicare Procedures & Services
141 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 379 | 1,140 | $153,900 | $104,523 | 67.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 267 | 354 | $68,910 | $45,621 | 66.2% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 224 | 260 | $52,000 | $16,022 | 30.8% |
| 86003 | Measurement of antibody (ige) to allergic substance, crude allergen extract, each | Office | 2023 | 100 | 3,060 | $30,600 | $15,654 | 51.2% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 100 | 4,080 | $40,800 | $12,715 | 31.2% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 107 | 111 | $33,300 | $10,196 | 30.6% |
| 82306 | Vitamin d-3 level | Office | 2023 | 221 | 287 | $18,655 | $8,326 | 44.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 353 | 829 | $8,290 | $6,964 | 84.0% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 107 | 111 | $38,850 | $6,758 | 17.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 87 | $8,265 | $5,713 | 69.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 45 | 46 | $12,650 | $5,198 | 41.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 203 | 306 | $13,770 | $5,037 | 36.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 296 | 510 | $15,300 | $4,855 | 31.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 190 | 201 | $10,452 | $4,577 | 43.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $5,750 | $3,624 | 63.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $7,140 | $3,465 | 48.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 58 | 86 | $7,310 | $3,434 | 47.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 44 | 44 | $19,800 | $3,208 | 16.2% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 203 | 306 | $10,710 | $2,705 | 25.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 197 | 213 | $10,650 | $2,067 | 19.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 112 | 192 | $7,680 | $1,998 | 26.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 64 | 64 | $1,920 | $1,882 | 98.0% |
| 90672 | Influenza vaccine, quadrivalent for nasal administration | Office | 2023 | 62 | 62 | $2,170 | $1,688 | 77.8% |
| 86769 | Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody | Office | 2023 | 32 | 36 | $2,305 | $1,486 | 64.5% |
| 97112 | Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2023 | 22 | 59 | $3,245 | $1,343 | 41.4% |
About Dr. Ross Nochimson, M.D
Dr. Ross Nochimson, M.D is a Internal Medicine healthcare provider based in Lauderhill, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1023157500.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ross Nochimson, M.D has received a total of $10,283 in payments from pharmaceutical and medical device companies, with $779.47 received in 2024. These payments were reported across 573 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($10,016).
As a Medicare-enrolled provider, Nochimson has provided services to 17,211 Medicare beneficiaries, totaling 54,541 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 141 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Lauderhill, FL
- Active Since 02/05/2007
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1023157500
Products in Payments
- Ozempic (Drug) $950.11
- FARXIGA (Drug) $552.63
- Tymlos (Biological) $500.63
- TRELEGY ELLIPTA (Drug) $483.63
- XIFAXAN (Drug) $430.21
- Vascepa (Drug) $378.12
- JARDIANCE (Drug) $362.31
- Otezla (Drug) $354.40
- SOLIQUA (Drug) $335.22
- TRULICITY (Drug) $273.73
- SOLIQUA 100/33 (Biological) $243.29
- Kerendia (Drug) $239.78
- XARELTO (Drug) $232.73
- AirSeal (Device) $209.82
- BYSTOLIC (Drug) $209.50
- FREESTYLE LIBRE 2 (Device) $191.57
- Micra (Device) $182.65
- UBRELVY (Drug) $177.30
- FREESTYLE LIBRE 3 (Device) $155.10
- VRAYLAR (Drug) $143.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lauderhill
Dr. Sean Nochimson, D.o, D.O
Internal Medicine — Payments: $3,872
Dr. Jessica Geller, M.d, M.D
Internal Medicine — Payments: $990.36
Herbert Slavin, Md, MD
Internal Medicine — Payments: $717.60
Dr. Daniel Leon Roumain, M.d, M.D
Internal Medicine — Payments: $610.80
Dr. John Wolf, M.d, M.D
Internal Medicine — Payments: $189.45
Natasha Cedeno, M.d, M.D
Internal Medicine — Payments: $47.29